Sort by
Refine Your Search
-
Category
-
Field
-
partnering academic or industrial institutions and present research findings in discussions with collaborators. To be successful in this role, you will hold a PhD/DPhil (or close to completion) in Cell Biology
-
biomarkers to assess the effectiveness of pharmacological interventions and other treatments for sports injuries as an exemplar. Additionally, you will have the opportunity to work in other areas of Digital
-
biological sources (i.e. cell cultures, including iPSCs and other relevant tissues and specimens). It is essential that you hold a PhD/DPhil (or close to completion) in biology, chemical biology, pharmacology
-
neurodegenerative diseases, reporting to the Oxford-GSK IMCM co-director Professor John Todd and Dr Anna Sher, Director in Quantitative Systems Pharmacology at GSK, and with oversight from the Oxford-GSK IMCM
-
to investigate risk stratification and tailoring of pharmacological therapy in HCM. Candidates would ideally hold a relevant PhD/DPhil (or close to completion) in Biomedical Engineering, Computer
-
physiological factors and other biomarkers to assess the effectiveness of pharmacological interventions and other treatments for sports injuries as an exemplar. Additionally, you will have the opportunity